Research Spotlight
Antiviral proteins for COVID-19
In a new paper in Science, we report the design of potent antiviral proteins that bind coronavirus spike proteins and prevent the virus from infecting human cells.
Beyond the Institute
From Research Into Company
PvP Biologics is a spinout from IPD that was recently acquired by Takeda. Their designer enzyme, KumaMax, looks to help those with Celiac disease. This exciting research began as a collaborative undergraduate project.
GET INVOLVED
Citizen Scientists
Computers are smart, but they sometimes miss important things because of the way they are programmed. The same goes for researchers. This is where Foldit comes in: everyday people playing Foldit can help discover better protein designs through their unique creativity and ingenuity.